Effects of Botanical Microglia Modulators in Gulf War Illness

NCT02909686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-01-24

Study results available
· View outcomes & findings →

Summary

The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If one of those supplements helps the symptoms of GWI, it will give the investigators information about what is wrong in people with GWI.

Conditions

  • Gulf War Illness

Interventions

DIETARY_SUPPLEMENT

Boswellia Serrata

DIETARY_SUPPLEMENT

Curcumin

DIETARY_SUPPLEMENT

Epimedium

DIETARY_SUPPLEMENT

Fisetin

DIETARY_SUPPLEMENT

Luteolin

DIETARY_SUPPLEMENT

Nettle

DIETARY_SUPPLEMENT

Pycnogenol

DIETARY_SUPPLEMENT

Reishi Mushroom

DIETARY_SUPPLEMENT

Resveratrol

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Congressionally Directed Medical Research Programs

    collaborator FED
  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Jarred W Younger, PhD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
39 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-09-30
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909686 on ClinicalTrials.gov